Table 1.
Healthy Controls (n = 29) |
LTBI-ALL (n = 58) |
LTBI-ALL | ||
---|---|---|---|---|
LTBI-Non-CKD (n = 19) |
LTBI-ESRD (n = 39) |
|||
Age, year | 57.7 ± 15.0 * | 57.4 ± 13.3 | 49.1 ± 15.7 ¶ | 61.5 ± 9.8 |
Male sex | 17 (58.6) * | 37(63.8) | 9 (47.4) ¶ | 28 (71.8) |
Smoking | 3 (10.3) #§ | 13(22.4) | 1 (5.3) | 12 (30.8) |
BMI | 23.6 ± 3.8 | 23.7 ± 3.6 | 23.7 ± 4.1 | 23.7 ± 3.4 |
Underlying disease | ||||
ESRD | 0 | 39(67.2) | 0 | 39(100) |
Malignancy | 0 | 1(1.7) | 1 (5.3) | 0 |
Cirrhosis of liver | 0 | 0 | 0 | 0 |
Diabetes mellitus | 6 (20.7) | 8(13.8) | 1 (5.3) | 7 (17.9) |
Radiographic findings | ||||
No lesion | 26 (89.7) | 55(94.8) | 18 (94.7) | 37 (92.5) |
Lesion, not related to TB | 3 (10.3) | 3(5.2) | 1 (5.3) | 3 (7.7) |
Lesion, prior TB | 0 | 0 | 0 | 0 |
Hemoglobin, g/dL | 13.8 ± 1.5 *#§ | 11.8 ± 1.7 | 12.5 ± 2.0 ¶ | 11.4 ± 1.5 |
Blood leukocyte count,/μL | 6920 ± 1398 | 7050 ± 2332 | 7560 ± 2607 | 6801 ± 2178 |
Abbreviations: BMI, body mass index; CKD, chronic kidney disease; ESRD, end stage renal disease; LTBI, latent tuberculosis infection; TB, tuberculosis Data are presented as number (%) or mean ± standard deviation. * Statistical significance between healthy controls and LTBI-non-CKD group. # Statistical significance between healthy controls and LTBI-ESRD group. ¶ Statistical significance between LTBI-non-CKD and LTBI-ESRD group. § Statistical significance between healthy controls and LTBI-ALL group.